Pazopanib-induced severe acute liver injury: A case report.

Jin-Wook ChoiJeong-Ju YooSang Gyune KimYoung Seok KimSusie Chin

Published in: Medicine (2022)

In patients with renal cell carcinoma, pazopanib treatment requires clinical caution as it causes rare complications such as severe jaundice and acute cholestatic hepatitis.

Keyphrases

drug induced
liver injury
renal cell carcinoma
metastatic renal cell carcinoma
risk factors
early onset
oxidative stress
respiratory failure
endothelial cells
extracorporeal membrane oxygenation
mechanical ventilation